Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hopkins

Showing results (891-900 of 955) with videos related to

Pageof 96
Sort By:
Chemmedchem|February 16, 2022
Design, Synthesis and X-Ray Structural Studies of Potent HIV-1 Protease Inhibitors Containing C-4 Substituted Tricyclic Hexahydro-Furofuran Derivatives as P2 LigandsArun K Ghosh, Satish Kovela, Ashish Sharma, et al.
Journal of Medicinal Chemistry|September 25, 2018
Discovery, Structure-Activity Relationship, and Biological Characterization of a Novel Series of 6-((1 H-Pyrazolo[4,3- b]pyridin-3-yl)amino)-benzo[ d]isothiazole-3-carboxamides as Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 4 (mGlu<sub>4</sub>)Sean R Bollinger, Darren W Engers, Joseph D Panarese, et al.
Cancer Immunology Research|June 13, 2024
Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen ReceptorsJu-Fang Chang, Nils Wellhausen, Nils W Engel, et al.
Molecular Pharmacology|June 14, 2018
Discovery, Characterization, and Effects on Renal Fluid and Electrolyte Excretion of the Kir4.1 Potassium Channel Pore Blocker, VU0134992Sujay V Kharade, Haruto Kurata, Aaron M Bender, et al.
The American Journal of Tropical Medicine and Hygiene|May 2, 2009
Nigeria's war on terror: fighting dracunculiasis, onchocerciasis, lymphatic filariasis, and schistosomiasis at the grassrootsNgozi A Njepuome, Donald R Hopkins, Frank O Richards, et al.
Cell|May 19, 1995
beta-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activityH Zheng, M Jiang, M E Trumbauer, et al.
Bioorganic & Medicinal Chemistry Letters|May 2, 2016
Discovery of 3-aminopicolinamides as metabotropic glutamate receptor subtype 4 (mGlu4) positive allosteric modulator warheads engendering CNS exposure and in vivo efficacyRocco D Gogliotti, Darren W Engers, Pedro M Garcia-Barrantes, et al.
Bioorganic & Medicinal Chemistry Letters|June 29, 2012
Discovery of N-(4-methoxy-7-methylbenzo[d]thiazol-2-yl)isonicatinamide, ML293, as a novel, selective and brain penetrant positive allosteric modulator of the muscarinic 4 (M4) receptorJames M Salovich, Paige N Vinson, Douglas J Sheffler, et al.
Science Translational Medicine|August 18, 2017
mGlu<sub>7</sub> potentiation rescues cognitive, social, and respiratory phenotypes in a mouse model of Rett syndromeRocco G Gogliotti, Rebecca K Senter, Nicole M Fisher, et al.
The Journal of Biological Chemistry|July 29, 2011
Identification of ML204, a novel potent antagonist that selectively modulates native TRPC4/C5 ion channelsMelissa Miller, Jie Shi, Yingmin Zhu, et al.
Pageof 96

Showing results (891-900 of 955) with videos related to

Sort By:
Pageof 96
Chemmedchem|February 16, 2022
Design, Synthesis and X-Ray Structural Studies of Potent HIV-1 Protease Inhibitors Containing C-4 Substituted Tricyclic Hexahydro-Furofuran Derivatives as P2 LigandsArun K Ghosh, Satish Kovela, Ashish Sharma, et al.
Journal of Medicinal Chemistry|September 25, 2018
Discovery, Structure-Activity Relationship, and Biological Characterization of a Novel Series of 6-((1 H-Pyrazolo[4,3- b]pyridin-3-yl)amino)-benzo[ d]isothiazole-3-carboxamides as Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 4 (mGlu<sub>4</sub>)Sean R Bollinger, Darren W Engers, Joseph D Panarese, et al.
Cancer Immunology Research|June 13, 2024
Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen ReceptorsJu-Fang Chang, Nils Wellhausen, Nils W Engel, et al.
Molecular Pharmacology|June 14, 2018
Discovery, Characterization, and Effects on Renal Fluid and Electrolyte Excretion of the Kir4.1 Potassium Channel Pore Blocker, VU0134992Sujay V Kharade, Haruto Kurata, Aaron M Bender, et al.
The American Journal of Tropical Medicine and Hygiene|May 2, 2009
Nigeria's war on terror: fighting dracunculiasis, onchocerciasis, lymphatic filariasis, and schistosomiasis at the grassrootsNgozi A Njepuome, Donald R Hopkins, Frank O Richards, et al.
Cell|May 19, 1995
beta-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activityH Zheng, M Jiang, M E Trumbauer, et al.
Bioorganic & Medicinal Chemistry Letters|May 2, 2016
Discovery of 3-aminopicolinamides as metabotropic glutamate receptor subtype 4 (mGlu4) positive allosteric modulator warheads engendering CNS exposure and in vivo efficacyRocco D Gogliotti, Darren W Engers, Pedro M Garcia-Barrantes, et al.
Bioorganic & Medicinal Chemistry Letters|June 29, 2012
Discovery of N-(4-methoxy-7-methylbenzo[d]thiazol-2-yl)isonicatinamide, ML293, as a novel, selective and brain penetrant positive allosteric modulator of the muscarinic 4 (M4) receptorJames M Salovich, Paige N Vinson, Douglas J Sheffler, et al.
Science Translational Medicine|August 18, 2017
mGlu<sub>7</sub> potentiation rescues cognitive, social, and respiratory phenotypes in a mouse model of Rett syndromeRocco G Gogliotti, Rebecca K Senter, Nicole M Fisher, et al.
The Journal of Biological Chemistry|July 29, 2011
Identification of ML204, a novel potent antagonist that selectively modulates native TRPC4/C5 ion channelsMelissa Miller, Jie Shi, Yingmin Zhu, et al.
Pageof 96